Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.

Okabe J, Orlowski C, Balcerczyk A, Tikellis C, Thomas MC, Cooper ME, El-Osta A.

Circ Res. 2012 Apr 13;110(8):1067-76. doi: 10.1161/CIRCRESAHA.112.266171. Epub 2012 Mar 8.

2.

Glycemic memory associated epigenetic changes.

Siebel AL, Fernandez AZ, El-Osta A.

Biochem Pharmacol. 2010 Dec 15;80(12):1853-9. doi: 10.1016/j.bcp.2010.06.005. Epub 2010 Jun 19. Review.

PMID:
20599797
3.

Epigenetics: mechanisms and implications for diabetic complications.

Cooper ME, El-Osta A.

Circ Res. 2010 Dec 10;107(12):1403-13. doi: 10.1161/CIRCRESAHA.110.223552. Review.

4.

Regulation of vascular genes by glucose.

Stenina OI.

Curr Pharm Des. 2005;11(18):2367-81. Review.

PMID:
16022672
6.

Regulation and function of H3K9 methylation.

Shinkai Y.

Subcell Biochem. 2007;41:337-50. Review.

PMID:
17484135
7.

Coupling mitosis to DNA replication: the emerging role of the histone H4-lysine 20 methyltransferase PR-Set7.

Brustel J, Tardat M, Kirsh O, Grimaud C, Julien E.

Trends Cell Biol. 2011 Aug;21(8):452-60. doi: 10.1016/j.tcb.2011.04.006. Epub 2011 May 31. Review.

PMID:
21632252
8.

Glycemic memories and the epigenetic component of diabetic nephropathy.

Keating ST, El-Osta A.

Curr Diab Rep. 2013 Aug;13(4):574-81. doi: 10.1007/s11892-013-0383-y. Review.

PMID:
23639991
9.

Chromatin modifications associated with diabetes.

Keating ST, El-Osta A.

J Cardiovasc Transl Res. 2012 Aug;5(4):399-412. doi: 10.1007/s12265-012-9380-9. Epub 2012 May 26. Review.

PMID:
22639343
10.

[The biological functions of lysine methyltransferase PR-SET7].

Liang XQ, Du YP, Wang DL, Yang Y.

Yi Chuan. 2013 Mar;35(3):241-54. Review. Chinese.

PMID:
23575530
11.

Role of epigenetic mechanisms in the vascular complications of diabetes.

Reddy MA, Natarajan R.

Subcell Biochem. 2013;61:435-54. doi: 10.1007/978-94-007-4525-4_19. Review.

PMID:
23150262
12.

Diabetes-induced epigenetic signature in vascular cells.

Mitić T, Emanueli C.

Endocr Metab Immune Disord Drug Targets. 2012 Jun;12(2):107-17. Review.

PMID:
22236027
13.

Histone lysine methylation in diabetic nephropathy.

Sun GD, Cui WP, Guo QY, Miao LN.

J Diabetes Res. 2014;2014:654148. doi: 10.1155/2014/654148. Epub 2014 Aug 25. Review.

14.

A new regulator of the cell cycle: the PR-Set7 histone methyltransferase.

Wu S, Rice JC.

Cell Cycle. 2011 Jan 1;10(1):68-72. Epub 2011 Jan 1. Review.

15.

Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications.

Togliatto G, Dentelli P, Brizzi MF.

J Diabetes Res. 2015;2015:373708. doi: 10.1155/2015/373708. Epub 2015 Apr 30. Review.

16.

Metabolic memory: mechanisms and implications for diabetic vasculopathies.

Zhang E, Wu Y.

Sci China Life Sci. 2014 Aug;57(8):845-51. doi: 10.1007/s11427-014-4710-6. Epub 2014 Aug 8. Review.

PMID:
25104458
17.

Hyperglycemic memory in metabolism and cancer.

Lee C, An D, Park J.

Horm Mol Biol Clin Investig. 2016 May 1;26(2):77-85. doi: 10.1515/hmbci-2016-0022. Review.

PMID:
27227713

Supplemental Content

Support Center